Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biohaven (BHVN) Operating Expenses (2021 - 2026)

Biohaven has reported Operating Expenses over the past 6 years, most recently at $130.4 million for Q1 2026.

  • Quarterly results put Operating Expenses at $130.4 million for Q1 2026, down 41.13% from a year ago — trailing twelve months through Mar 2026 was $654.2 million (down 29.15% YoY), and the annual figure for FY2025 was $745.4 million, down 15.79%.
  • Operating Expenses reached $130.4 million in Q1 2026 per BHVN's latest filing, down from $142.7 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $333.8 million in Q2 2024 and bottomed at $67.6 million in Q3 2022.
  • Median Operating Expenses over the past 5 years was $169.4 million (2025), compared with a mean of $162.6 million.
  • The largest annual shift saw Operating Expenses surged 319.42% in 2022 before it crashed 52.31% in 2023.
  • Over 5 years, Operating Expenses stood at $213.4 million in 2022, then dropped by 27.97% to $153.7 million in 2023, then grew by 23.56% to $189.9 million in 2024, then decreased by 24.85% to $142.7 million in 2025, then decreased by 8.62% to $130.4 million in 2026.
  • Business Quant data shows Operating Expenses for BHVN at $130.4 million in Q1 2026, $142.7 million in Q4 2025, and $169.4 million in Q3 2025.